Photo

Photo detail

Kleanthis Xanthopoulos

Stories this photo appears in:

Trump's Proposed Budget Cuts Seen as 'Catastrophic' By Some Local Biotech Leaders

President Donald Trump’s blueprint is out for next year’s federal budget, and proposed cuts to scientific programs are causing local biotech leaders to balk.

Tease photo

Some Local Biotech Leaders See Trump's Proposed Budget Cuts as 'Catastrophic'

President Donald Trump’s blueprint is out for next year’s federal budget, and proposed cuts to scientific programs are causing local biotech leaders to balk.

Tease photo

Regulus CEO Apruptly Resigns; Chief Science Officer Also Leaving

Kleanthis Xanthopoulos, who has served more than seven years at the helm of San Diego microRNA drug developer Regulus Therapeutics, unexpectedly resigned as CEO and from the company’s board, according to a statement from the company.

Tease photo